HomeArsenal Medical

Arsenal Medical

U.S. Food and Drug Administration Grants Arsenal Medical Investigational Device Exemption Approval to Conduct Clinical Study on ResQFoam Safety and Effectiveness

Arsenal Medical announced today they have received unconditional IDE approval from FDA to conduct a clinical study to examine the safety and effectiveness of ResQFoamTM, a self-expanding material for the treatment of severe internal bleeding in trauma...